MEDESIS PHARMA (EPA:ALMDP) | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
MEDESIS PHARMA

REGULATED PRESS RELEASE

published on 11/20/2024 at 17:45, 15 hours 59 minutes ago

MEDESIS PHARMA A FINALISÉ L’ÉTUDE CLINIQUE POUR LE TRAITEMENT DE LA MALADIE D’ALZHEIMER AVEC LE NANOLITHIUM
REGULATED PRESS RELEASE

published on 11/20/2024 at 17:45, 15 hours 59 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
REGULATED PRESS RELEASE

published on 11/14/2024 at 18:00, 6 days 15 hours ago

MEDESIS PHARMA : CONVERSION DE LA PROCÉDURE DE SAUVEGARDE EN REDRESSEMENT JUDICIAIRE
REGULATED PRESS RELEASE

published on 11/12/2024 at 18:00, 8 days 15 hours ago

MEDESIS PHARMA : Activités & résultats du 1er semestre 2024
REGULATED PRESS RELEASE

published on 10/08/2024 at 08:00, 1 month 13 days ago

Participation de MEDESIS PHARMA au Congrès mondial pour les études cliniques sur la Maladie d’Alzheimer à Madrid fin octobre 2024 (CTAD - Clinical Trials Alzheimer’s Disease)
REGULATED PRESS RELEASE

published on 10/08/2024 at 08:00, 1 month 13 days ago

MEDESIS PHARMA to participate to the World Congress for Clinical Trials in Alzheimer’s Disease, in Madrid at the end of October 2024 (CTAD, Clinical Trials Alzheimer’s Disease)
BRIEF

published on 09/20/2024 at 08:05, 2 months 1 day ago

Encouraging results from NanoLithium trial on Alzheimer's disease

Biotechnology Alzheimer Nanolithium Clinical Trial Tolérance
BRIEF

published on 09/20/2024 at 08:05, 2 months 1 day ago

Résultats encourageants de l'essai NanoLithium sur la maladie d'Alzheimer

Biotechnologie Alzheimer Nanolithium Essai Clinique Tolérance
REGULATED PRESS RELEASE

published on 09/20/2024 at 08:00, 2 months 1 day ago

MEDESIS PHARMA : Résultats encourageants de la première phase de l’essai clinique de phase 2a pour le traitement de la maladie d’Alzheimer avec le NanoLIthium
Résultats encourageants de l'étude clinique de phase 2a pour le NanoLithium dans le traitement de la maladie d'Alzheimer. Premiers résultats positifs démontrant bonne tolérance et efficacité

Nanolithium Essai Clinique Sécurité Efficacité Maladie D'Alzheimer
REGULATED PRESS RELEASE

published on 09/04/2024 at 17:45, 2 months 16 days ago

MEDESIS PHARMA : MISE À DISPOSITION DES DOCUMENTS PRÉPARATOIRES À L’ASSEMBLÉE GÉNÉRALE MIXTE DU 25 SEPTEMBRE 2024

1 2 ... 4

Accesswire

Published on 11/21/2024 at 09:00, 44 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 9 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 19 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 44 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 44 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 43 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 44 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 44 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 29 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 35 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 46 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 46 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 46 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 37 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 24 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE